Delivery Order SPE2DB22D3019-SPE2DB25FK4DA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,914.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pen injectors on November 5, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and is scheduled for completion by November 6, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division. This...
- The Defense Logistics Agency awarded a $3,169.95 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $2,852.85 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trulicity 3 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,747.04 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml) on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $1,792.32. This is a firm fixed price delivery order with an ultimate completion date of August 7, 2025, executed without a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as a child delivery order under its larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $4,059.96. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the major pharmaceutical distributor. The contract has an ultimate completion date of September 15, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,178.75 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on November 24, 2025, with completion expected by November 25, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen auto-injectors with a ceiling value of $1,162.96 and a completion date of November 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military...
- The Defense Logistics Agency awarded a delivery order valued at $11,078.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on September 11, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical supplier to federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $1,651.65. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4DADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,861.34 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pen injectors on August 21, 2025, with completion scheduled for August 22, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this delivery order from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with Trulicity (a diabetes medication) being representative of the broad therapeutic categories available through this prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 8/21/25 |